Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$0.77
-1.3%
$1.15
$0.75
$2.03
$29.17M1.05175,551 shs500,783 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
Max Resource Corp. stock logo
MXR
Max Resource
C$0.42
-5.7%
C$0.41
C$0.14
C$0.46
C$40.71MN/A285,195 shs357,400 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-1.90%-41.29%-30.18%-31.42%-59.42%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
Max Resource Corp. stock logo
MXR
Max Resource
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
2.8017 of 5 stars
4.00.00.00.02.33.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
Max Resource Corp. stock logo
MXR
Max Resource
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
2.00
Hold$3.50357.52% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
Max Resource Corp. stock logo
MXR
Max Resource
N/AN/AN/AN/A

Current Analyst Ratings

Latest MXR, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$3.00 ➝ $1.00
5/15/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
5/15/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
5/15/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$6.00 ➝ $1.50
5/14/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
(Data available from 5/22/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M3.70N/AN/A$2.73 per share0.28
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
Max Resource Corp. stock logo
MXR
Max Resource
N/AN/AC$0.02 per share19.76C$0.04 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.66N/AN/AN/A-556.59%-51.74%-37.70%8/5/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A8/6/2024 (Estimated)
Max Resource Corp. stock logo
MXR
Max Resource
N/A-C$0.06N/AN/AN/AN/AN/AN/A

Latest MXR, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024Q1 2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.30C$0.35+C$0.05C$0.35N/AC$182.89 million
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
Max Resource Corp. stock logo
MXR
Max Resource
N/AN/AN/AN/AN/A

Latest MXR, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.075/31/20245/31/20246/17/2024
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.16
5.68
5.68
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
Max Resource Corp. stock logo
MXR
Max Resource
N/A
6.36
5.63

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Max Resource Corp. stock logo
MXR
Max Resource
N/A

Insider Ownership

CompanyInsider Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
30.90%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Max Resource Corp. stock logo
MXR
Max Resource
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million26.35 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
Max Resource Corp. stock logo
MXR
Max Resource
N/A98.08 millionN/ANot Optionable

MXR, BOLT, CZX, and FCR Headlines

Recent News About These Companies

Max Service Group Names New President
Mad Max: Fury Road Ending, Explained
7 Best New Movies To Watch on Max in March 2024
MAX USA Is Building Tomorrow At World Of Concrete 2024
Max Homa odds, tips and betting trends for The Sentry

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
Max Resource logo

Max Resource

CVE:MXR
Max Resource Corp. engages in the acquisition and exploration of mineral properties in Canada, Peru, and Colombia. The company holds interests in the Choco gold project covering 250 square kilometers; North Choco gold-copper project covering 250 square kilometers; Gachala copper project covering 164 square kilometers; Novita project covering 10,790 hectares located in Colombia; and Cesar copper silver project, which covers an area of approximately 2,000 hectares located in Colombia. It also holds 100% interest in the RT Gold property consists of two contiguous mineral concessions covering 1,983 hectares and sits along the Condor mountain chain of northern Peru. The company was formerly known as Vancan Capital Corp. and changed its name to Max Resource Corp. in May 2004. Max Resource Corp. was incorporated in 1994 and is headquartered in Vancouver, Canada.